Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25042194 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Annarosa Floreani und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Padova, 35122 Padova, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Cirrhosis, Biliary, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterised by the immune-mediated destruction of small and medium intrahepatic bile ducts, with variable outcomes and progression. This review summarises the state of the art regarding the risk of neoplastic progression in PBC patients, with a particular focus on the molecular alterations present in PBC and in hepatocellular carcinoma (HCC), which is the most frequent liver cancer in these patients. Major risk factors are male gender, viral infections, e.g., HBV and HCV, non-response to UDCA, and high alcohol intake, as well as some metabolic-associated factors. Overall, HCC development is significantly more frequent in patients with advanced histological stages, being related to liver cirrhosis. It seems to be of fundamental importance to unravel eventual dysfunctional molecular pathways in PBC patients that may be used as biomarkers for HCC development. In the near future, this will possibly take advantage of artificial intelligence-designed algorithms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Padova, 35122 Padova, Italy.
- Scientific Consultant IRCCS Negrar, 37024 Verona, Italy.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.
ORCID-Profile: Daniela Gabbia, Sara De Martin
Zitieren
APA
Floreani, A., Gabbia, D., & De Martin, S. (2024). Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042194
Vancouver
Floreani A, Gabbia D, De Martin S. Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042194
BibTeX
@article{Floreani2024,
author = {Floreani, Annarosa and Gabbia, Daniela and De Martin, Sara},
title = {Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25042194}
}
EUVIMED